First world success

The first cord blood transplant (CBT) was made possible by an intensive collaboration among three groups: AD. Auerbach from the Rockefeller University in New York (USA) described a method of prenatal diagnosis in Fanconi anemia (FA); HE. Broxmeyer from Indiana University in Indianapolis (USA) systematically analyzed the number of hematopoietic cell progenitors in cord blood for the purpose of using the cells for hematopoietic reconstitution in humans; and E. Gluckman from Hospital Saint Louis in Paris (France) showed that the in vivo hypersensibility of FA cells translated into an increased toxicity of the pretransplant-conditioning regimen used in aplastic anemia. Moreover, she was the first to use a modified attenuated dose conditioning in these patients with improved short- and long-term survival. Bone Marrow Transplantation (2009) 44, 621–626.

Since the first CBT, more than 20 000 CBTs have been reported worldwide and more than 400 000 cord blood units have been stored in more than 100 cord blood banks (source: Bone Marrow Donors Worldwide (BMDW), January 2009).

Eliane Gluckman - Cords For Life

Eurocord Monaco

MONACORD is a clinical research organisation, which has established at the Centre Scientifique de Monaco

Read more